What is menopausal vaginal dryness, and how is it treated safely in Europe?

Menopausal vaginal dryness explained: genitourinary syndrome of menopause (GSM), oestrogen decline, vaginal atrophy, dyspareunia, and treatment criteria.

In this episode, we outline why vaginal dryness occurs during menopause and how doctors assess treatment options under EU medical guidance.

You’ll learn:

• How declining oestrogen affects vaginal tissue thickness and lubrication

• Common symptoms: dryness, itching, burning, painful intercourse

• The difference between vaginal dryness and infection

• First-line options: vaginal moisturisers and lubricants

• When low-dose local vaginal oestrogen may be considered

• Safety considerations for women with breast cancer history

• Red flag symptoms such as unexplained bleeding, persistent pain, or abnormal discharge

• Situations where hormone therapy requires individual risk assessment

We explain how doctors assess symptom severity, menopausal status, sexual discomfort, urinary symptoms, medical history, and contraindications during an online consultation in the EU. Treatment decisions are based on symptom impact and individual risk profile.

This episode reflects the clinical standards used by Mobi Doctor, where women’s health consultations are reviewed by a registered physician in line with EU medical guidance.

Read the full guide and transcript here:

https://www.mobidoctor.eu/blog/what-is-menopausal-vaginal-dryness-and-how-do-we-treat-it